Epstein-Barr virus lytic replication and cancer

Epidemiological studies have provided strong evidence that Epstein-Barr virus (EBV) lytic replication is linked to cancer development. Evidence of abortive lytic replication in some tumors and infections with recombinant viruses incapable of lytic replication in animal models have reinforced this vi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Li, Hao (VerfasserIn) , Lee, Chih-Ying (VerfasserIn) , Delecluse, Henri-Jacques (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2025
In: Current opinion in virology
Year: 2025, Jahrgang: 70, Pages: 1-12
ISSN:1879-6265
DOI:10.1016/j.coviro.2024.101438
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.coviro.2024.101438
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S187962572400052X
Volltext
Verfasserangaben:Hao Li, Chih-Ying Lee and Henri-Jacques Delecluse
Beschreibung
Zusammenfassung:Epidemiological studies have provided strong evidence that Epstein-Barr virus (EBV) lytic replication is linked to cancer development. Evidence of abortive lytic replication in some tumors and infections with recombinant viruses incapable of lytic replication in animal models have reinforced this view. Furthermore, multiple lytic proteins have been shown to induce genetic instability, a well-characterized precancerous state. In particular, lytic proteins dysregulated the DNA damage response, interfered with cell cycle progression, and induced the development of structural genetic abnormalities. However, there is so far no direct evidence from in vivo or in vitro studies that lytic replication alone can induce cancer. Here, we critically review the currently available evidence that EBV lytic replication contributes to cancer development and suggest future research directions.
Beschreibung:Gesehen am 16.01.2026
Beschreibung:Online Resource
ISSN:1879-6265
DOI:10.1016/j.coviro.2024.101438